Khattar Jack A.
SEC insider (Form 3/4/5 filer). CIK 0001539937. President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN) and 2 other issuers. 80 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in ROCKVILLE, MD.
Companies Khattar Jack A. has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Director, Officer, President, CEO
- COGNITION THERAPEUTICS INC (CGTX): Director
- scPharmaceuticals Inc. (SCPH): Director
Khattar Jack A.
CIK: 0001539937
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (80 total)
- Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect12.6K shares at avg. $46.57$589K - Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect29.8K shares- - Jul 29, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectPerformance Share Unit
29.8K shares- - Jun 17, 2026CGTX
COGNITION THERAPEUTICS INC
AwardDirect25K shares- - Mar 13, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleIndirect10.7K shares at avg. $51.00$548K - Mar 13, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
OtherDirect12.5K shares- - Mar 13, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
OtherIndirect12.5K shares- - Mar 13, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleIndirect24.1K shares at avg. $50.09$1.2M - Mar 13, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleIndirect120 shares at avg. $51.75$6K - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect38.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 |  SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 12,642 | $46.57 | $588,738 | Direct |
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 29,849 | - | $0 | Direct |
| Jul 29, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Performance Share Unit | 29,849 | - | - | Direct |
| Jun 17, 2026 |  CGTX COGNITION THERAPEUTICS INC | Award | 25,000 | - | $0 | Direct |
| Mar 13, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 10,742 | $51.00 | $547,842 | Indirect |
| Mar 13, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Other | 12,500 | - | $0 | Direct |
| Mar 13, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Other | 12,500 | - | $0 | Indirect |
| Mar 13, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 24,138 | $50.09 | $1,209,072 | Indirect |
| Mar 13, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 120 | $51.75 | $6,210 | Indirect |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 38,640 | - | $0 | Direct |
1-10 of 80 transactions